The KEGG analysis result revealed that YFSJF produced therapeutic effects on NSCLC by regulating multiple pathways (e.g., pathways in cancer, PI3K-AKT signaling pathway, proteoglycans in cancer, HIF-1 signaling pathway, ErbB signaling pathway, and VEGF signaling pathway). Here, AKT1 is linked to non-small cell lung carcinoma.